Senior Market Access Manager - EMEA

🌍 Making every move matter

At ViCentra, we’re on a mission to redefine what’s possible in diabetes care. We combine technological innovation with human-centered design to empower people with more freedom, confidence, and life on their terms. Our values;
Be Bold, Build Trust, Focus on the Customer and Deliver Excellence drive everything we create and every decision we make.

We believe that when ambition meets purpose, remarkable things happen. If you thrive in a space where ideas accelerate, challenges spark growth, and making a difference is the goal, ViCentra is your next great adventure. 🚀

As our Senior Market Access Manager for the Kaleido insulin pump, you will be responsible for shaping and executing market access and reimbursement strategies across key European markets.

• Develop and execute integrated market access strategies for Germany, France and the Netherlands, aligned with commercial plans.

• Shape market entry strategies and access roadmaps for new markets such as the UK, Italy, Spain and Australia, including sequencing of HTA submissions, pricing and contracting approach.

• Translate Kaleido’s clinical and user benefits into compelling value propositions tailored to payers, HTA bodies, clinicians and patient organisations.

• Lead or support reimbursement and funding processes in priority markets (e.g. GKV in Germany, NHS England, regional decision makers in Spain).

• Coordinate HTA dossiers, reimbursement submissions and tender documentation, working closely with internal teams and external consultants.

• Provide input into pricing strategies and value-based pricing models across markets.

• Monitor and anticipate changes in policy, reimbursement frameworks and benefit structures affecting insulin pumps, CGM and hybrid closed loop systems, and translate implications into concrete actions.

• Build and maintain long-term relationships with national and regional payers, assessors, diabetes clinical leaders and patient organisations.

• Design and execute payer engagement plans, including advisory boards, early scientific advice, budget impact discussions and contract negotiations.

• Partner with Medical Affairs to ensure real-world evidence and clinical data support reimbursement, renewals and tenders.

• Act as the interface between Leadership, Marketing and Commercial teams, ensuring alignment between access conditions, launch sequence and commercial execution.

• Provide market access insights into brand planning, launch readiness, forecasting and life-cycle management.

• Train internal teams and distribution partners on value messages, reimbursement pathways and access tools.

• Analyse market access performance (time to reimbursement, coverage levels, patient access metrics) and identify opportunities to improve.

• Benchmark against other insulin pump and CGM manufacturers in Europe to ensure competitiveness in access and value communication.

You have proven experience securing reimbursement for medical devices or diabetes therapies in Europe, and you’re motivated to help scale a fast-growing challenger in the insulin pump market. In this role, you’ll play a key part in ensuring people living with type 1 diabetes gain sustainable access to Kaleido in both existing and new markets.

• Master’s degree in Health Economics, Pharmacy, Life Sciences, Public Health, Business or a related field.

• 5+ years of Market Access / Reimbursement experience in the pharmaceutical or medical device industry, with at least part of that in diabetes, endocrinology, medical devices or digital health.

• Proven track record of successfully obtaining or defending reimbursement for innovative therapies or devices in at least one of:
  Germany, France, Netherlands, UK, Italy, or Spain.

• Strong experience with payers / HTA processes (e.g. dossier development, value dossiers, budget impact models, HTA interactions, tenders).

• Experience working in or with similar Med Tech organisations is a strong plus.

• Fluent English (written and spoken) is a must. Fluency in German or Dutch is strongly preferred;
  French, Italian or Spanish are clear advantages.

• Deep understanding of European healthcare systems,…